BAL PHARMA
Back to Balance Sheet
|
BAL PHARMA Last 5 Year Total Debt History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Debt | ₹150 Cr | ₹140 Cr | ₹131 Cr | ₹104 Cr | ₹110 Cr |
What is the latest Total Debt ratio of BAL PHARMA ?
| Year | Total Debt |
|---|---|
| Mar2025 | ₹150 Cr |
| Mar2024 | ₹140 Cr |
| Mar2023 | ₹131 Cr |
| Mar2022 | ₹104 Cr |
| Mar2021 | ₹110 Cr |
How is Total Debt of BAL PHARMA Trending?
| Years | Total Debt | % Change | |
|---|---|---|---|
| Mar2025 | ₹150 Cr | 7.72 | |
| Mar2024 | ₹140 Cr | 6.56 | |
| Mar2023 | ₹131 Cr | 26.40 | |
| Mar2022 | ₹104 Cr | -5.80 | |
| Mar2021 | ₹110 Cr | - | |
Compare Total Debt of peers of BAL PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BAL PHARMA | ₹132.6 Cr | -3% | -4.2% | -3.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹456,114.0 Cr | NA | -3.9% | 17.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹239,321.0 Cr | 5% | 21.5% | 44.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹185,924.0 Cr | -2.1% | -0.2% | 34.3% | Stock Analytics | |
| CIPLA | ₹113,778.0 Cr | -2% | -2.5% | -8.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,025.9 Cr | 0.4% | 4.5% | -4.4% | Stock Analytics | |
BAL PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BAL PHARMA | -3% |
-4.2% |
-3.1% |
| SENSEX | 0.7% |
0.8% |
-5.1% |
You may also like the below Video Courses